Drug-Related Problems Increase Healthcare Costs for People Living with Dementia
- 23 December 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 73 (2) , 791-799
Abstract
Background: Drug-related problems (DRP) are common in the elderly population, especially in people living with dementia (PwD). DRP are associated with adverse outcomes that could result in increased costs. Objective: The objective of the study was to analyze the association between DRP and healthcare costs in PwD. Methods: The analysis was based on the cross-sectional data of 424 PwD. Compliance, adverse effects, and drug administration of prescribed and over-the-counter drugs taken were assessed. DRP were identified and classified by pharmacists using an adapted German version of “PIE-Doc ® ”. Healthcare utilization was assessed retrospectively used to calculated costs from a public payer perspective using standardized unit costs. The associations between DRP and healthcare costs were analyzed using multiple linear regression models. Results: 394 PwD (93%) had at least one DRP. An inappropriate drug choice was significantly associated with increased total costs ( b = 2,718€; CI95% 1,448–3,988) due to significantly higher costs for hospitalization ( b = 1,936€; 670–3,202) and for medications ( b = 417€; 68–765). Problems with medication dosage and drug interactions were significantly associated with higher medication costs ( b = 679€; 31–1,328; and b = 630€; 259–1,001, respectively). Conclusions: DRP could significantly lead to adverse outcomes for PwD and healthcare payers, reflected by a higher hospitalization and costs, respectively. Further research is needed to clarify on interventions and approaches efficiently avoiding DRP and on the effect on patient-reported and economic outcomes.Keywords
This publication has 38 references indexed in Scilit:
- Medication management for people with dementia in primary care: description of implementation in the DelpHi studyBMC Geriatrics, 2013
- Life- and person-centred help in Mecklenburg-Western Pomerania, Germany (DelpHi): study protocol for a randomised controlled trialTrials, 2012
- Drug-related problems (DRPs) identified from geriatric medication safety review clinicsArchives of Gerontology and Geriatrics, 2012
- Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementiaBMC Psychiatry, 2011
- Medication errors in elderly people: contributing factors and future perspectivesBritish Journal of Clinical Pharmacology, 2009
- Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug‐related problemsBritish Journal of Clinical Pharmacology, 2006
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Comorbidity Profile of Dementia Patients in Primary Care: Are They Sicker?Journal of the American Geriatrics Society, 2005
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Development and validation of a geriatric depression screening scale: A preliminary reportJournal of Psychiatric Research, 1982